NCT03538431View on ClinicalTrials.gov

Improving Driving in Young People With Autism Spectrum Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Buspirone

Buspirone is an atypical anxiolytic medication.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts Institute of Technology

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03538431 - Improving Driving in Young People With Autism Spectrum Disorders | Biotech Hunter | Biotech Hunter